3-methyl-4-(2,2,2-trifluoro-acetylamino)-benzenesulfonyl chloride | 943654-22-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-methyl-4-(2,2,2-trifluoro-acetylamino)-benzenesulfonyl chloride
• 英文别名: 3-methyl-4-(2,2,2-trifluoroacetamido)benzene-1-sulfonyl chloride；3-methyl-4-[(2,2,2-trifluoroacetyl)amino]benzenesulfonyl chloride
• CAS: 943654-22-6
• 化学式: C₉H₇ClF₃NO₃S
• 分子量: 301.674
• InChiKey: WJDSLFCXCFXWEQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  71.6
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  3-methyl-4-(2,2,2-trifluoro-acetylamino)-benzenesulfonyl chloride 在 盐酸 、 碳酸氢钠 、 sodium hydroxide 作用下， 以 乙醚 、 乙醇 、 水 、 丙酮 为溶剂， 反应 3.0h， 生成 1-(4-amino-3-methylphenylsulfonyl)-5-methyl-4-phenylimidazolidin-2-one
  参考文献：
  名称：

  芳基磺酰亚胺咪唑烷酮类抗癌剂的构效关系研究

  摘要：

  为了找到新型的N-芳基磺酰亚胺基咪唑啉酮类强效抗癌药，通过对2-甲基-4-（2-氧代-4-苯基咪唑烷基-1-基磺酰基）苯基氨基甲酸酯的结构和活性关系进行了探索。其类似物对HCT116，A549和NCL-H460癌细胞系的体外细胞毒性。在合成的衍生物中，氨基甲酸酯类似物（4a - f和4k - p）对所有癌细胞系均表现出对阿霉素的优异细胞毒性。这些衍生物的SAR研究证实，完整的4-苯基-1-苯磺酰氨基咪唑啉酮作为基本药效团具有关键作用，仅在1-氨基苯磺酰基部分的2位疏水取代有利于增强活性。

  DOI：

  10.1016/j.bmcl.2011.09.025
• 作为产物：
  描述：

  邻甲苯胺 在 吡啶 、 氯磺酸 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成 3-methyl-4-(2,2,2-trifluoro-acetylamino)-benzenesulfonyl chloride
  参考文献：
  名称：

  Novel diarylsulfonylurea derivatives as potent antimitotic agents

  摘要：

  A novel series of diarylsulfonylurea derivatives were synthesized and evaluated for interaction with tubulin and for cytotoxicity against human cancer cell lines. These derivatives demonstrated good inhibitory activity against tubulin polymerization, which was well correlated with promising antiproliferative activity as well as G2/M phase cell cycle arrest. Furthermore, several compounds were also efficacious against multidrug-resistant cancer cells, which are resistant to many other known microtubule inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.09.069

文献信息

• Heterocyclic derivatives as modulators of ion channels
  申请人：Martinborough Esther

  公开号：US20080027067A1

  公开（公告）日：2008-01-31

  The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及用作离子通道抑制剂的杂环衍生物。该发明还提供了包括本发明化合物的药用可接受组合物，以及使用这些组合物治疗各种疾病的方法。
• [EN] ARYLSULFONYL PYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS<br/>[FR] DÉRIVÉS DE CARBOXAMIDINE DE PYRAZOLINE ARYLSULFONYLIQUE FORMANT DES ANTAGONISTES DE 5-HT6
  申请人：SOLVAY PHARM BV

  公开号：WO2009115515A1

  公开（公告）日：2009-09-24

  This invention concerns arylsulfonyl pyrazoline carboxamidine derivatives as antagonists of 5- HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes. The compounds have the general formula (1) wherein the symbols have the meanings given in the description.

  这项发明涉及芳基磺酰基吡唑啉羧酰胺衍生物作为5-HT6受体拮抗剂，以及用于制备这些化合物的方法和用于它们合成的新型中间体。该发明还涉及这些化合物和组合物的用途，特别是它们在向患者施用以达到在帕金森病、亨廷顿舞蹈症、精神分裂症、焦虑、抑郁症、躁郁症、精神病、癫痫、强迫性障碍、情绪障碍、偏头痛、阿尔茨海默病、与年龄相关的认知下降、轻度认知障碍、睡眠障碍、进食障碍、厌食症、暴食症、暴食症、恐慌发作、不安定症、注意力缺陷多动障碍、注意力缺陷障碍、戒除可卡因、乙醇、尼古丁或苯二氮卓类药物滥用、疼痛、与脊柱损伤或头部损伤相关的障碍、脑积水、功能性肠道障碍、肠易激综合征、肥胖和2型糖尿病中的治疗效果方面的应用。这些化合物具有一般公式（1），其中符号的含义如描述中所示。
• ARYLSULFONYL PYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS
  申请人：Loevezijn Arnold Van

  公开号：US20110046171A1

  公开（公告）日：2011-02-24

  This invention concerns arylsulfonyl pyrazoline carboxamidine derivatives as antagonists of 5-ht6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in parkinson's disease, huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, irritable bowel syndrome, obesity and type-2 diabetes. The compounds have the general formula (1) wherein the symbols have the meanings given in the description.

  本发明涉及芳基磺酰基吡唑啉羧酰胺衍生物，其作为5-ht6受体拮抗剂，以及用于制备这些化合物的方法和有用于它们的合成的新型中间体。该发明还涉及这些化合物和组合物的用途，特别是它们用于给患者治疗帕金森病、亨廷顿病、精神分裂症、焦虑症、抑郁症、躁郁症、精神病、癫痫、强迫症、情绪障碍、偏头痛、阿尔茨海默病、年龄相关的认知下降、轻度认知障碍、睡眠障碍、进食障碍、厌食症、贪食症、暴食症、惊恐发作、不安静脚症候群、注意力缺陷多动障碍、注意力缺陷障碍、戒断可卡因、乙醇、尼古丁或苯二氮平的滥用、疼痛、与脊髓创伤或头部损伤有关的疾病、脑积水、功能性肠道紊乱、肠易激综合征、肥胖症和2型糖尿病。这些化合物具有通式（1），其中符号的含义如描述中所给。
• Pyrrolidinyl phenyl sulphonamides as modulators of ion channels
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US08163720B2

  公开（公告）日：2012-04-24

  The present invention relates to phenyl sulfonamides useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, including for example the treatment of pain.

  本发明涉及苯基磺酰胺，其作为离子通道抑制剂的用途。本发明还提供了包含本发明化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病的方法，例如治疗疼痛。
• PHENYL SULFONAMIDES AS MODULATORS OF ION CHANNELS
  申请人：Martinborough Esther

  公开号：US20110082117A1

  公开（公告）日：2011-04-07

  The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

  本发明涉及杂环衍生物，可用作离子通道抑制剂。本发明还提供了包含本发明化合物的药学上可接受的组合物，并提供了使用这些组合物治疗各种疾病的方法。